Menard Financial Group LLC Biomarin Pharmaceutical Inc Transaction History

Menard Financial Group LLC

  • $135 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$71.72 - $91.47 $190,631 - $243,127
-2,658 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$74.77 - $85.47 $198,738 - $227,179
2,658 New
2,658 $205,000
Q3 2020

Nov 12, 2020
SELL
$71.87 - $131.03 $126,491 - $230,612
-1,760 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$79.55 - $124.22 $140,008 - $218,627
1,760 New
1,760 $217,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Menard Financial Group LLC Portfolio

Follow Menard Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menard Financial Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email